Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes
- Sponsor
- Joslin Diabetes Center
- Enrollment
- 75
- Locations
- 1
- Primary Endpoint
- Number of Missed Insulin Doses
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
In this cross-sectional study the investigators will examine two populations: young adults with (ages 18-35) and older adults (ages 65 and over) with diabetes who are on > 2 insulin injections per day. The sample size for this observational study will be up to 125 patients. The investigators will issue a Common Sensing GoCap bluetooth-enabled pen cap that fits on the end of Solostar Lantus and Apidra insulin pens; this pen cap registers the position of the insulin pen plunger and automatically sends confirmation of dose delivery to a smartphone app.
Investigators
Medha Munshi
Director of Joslin Geriatric Diabetes Programs Beth Israel Deaconess Medical Center Associate Professor of Medicine, Harvard Medical School
Joslin Diabetes Center
Eligibility Criteria
Inclusion Criteria
- •Type 1 diabetes or insulin-requiring Type 2 diabetes
- •\> 2 insulin injections
- •Age 18-35 or older than 65 years
- •Use of glargine insulin as basal insulin
- •Stable insulin doses for past 3 months
Exclusion Criteria
- •Previous tape/adhesive allergies with CGM sensors
- •Visual or cognitive impairment with inability to self-administer insulin
Outcomes
Primary Outcomes
Number of Missed Insulin Doses
Time Frame: 4 week use of blue tooth pen cap